Format

Send to

Choose Destination
Am J Public Health. 2008 Dec;98(12):2123-33. doi: 10.2105/AJPH.2007.128231. Epub 2008 Oct 15.

Corporate philanthropy, lobbying, and public health policy.

Author information

1
Center for Tobacco Control Research and Education, University of California, San Francisco, USA.

Abstract

To counter negative publicity about the tobacco industry, Philip Morris has widely publicized its philanthropy initiatives. Although corporate philanthropy is primarily a public relations tool, contributions may be viewed as offsetting the harms caused by corporate products and practices. That such donations themselves have harmful consequences has been little considered. Drawing on internal company documents, we explored the philanthropy undertaken as part of Philip Morris's PM21 image makeover. Philip Morris explicitly linked philanthropy to government affairs and used contributions as a lobbying tool against public health policies. Through advertising, covertly solicited media coverage, and contributions to legislators' pet causes, Philip Morris improved its image among key voter constituencies, influenced public officials, and divided the public health field as grantees were converted to stakeholders.

PMID:
18923118
PMCID:
PMC2636524
DOI:
10.2105/AJPH.2007.128231
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center